We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+14.69%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$12.1B
AUM Growth
+$469M
Cap. Flow
-$38.2M
Cap. Flow %
-0.32%
Top 10 Hldgs %
18.63%
Holding
466
New
91
Increased
122
Reduced
152
Closed
85

Top Buys

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$124M
2
FLS icon
Flowserve
FLS
+$81.8M
3
CORZ icon
Core Scientific
CORZ
+$80.1M
4
CCJ icon
Cameco
CCJ
+$66.8M
5
YUMC icon
Yum China
YUMC
+$65.5M

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 22.49%
3 Industrials 17.85%
4 Consumer Discretionary 12.06%
5 Financials 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSPI icon
301
Kaspi.kz JSC
KSPI
$17.5B
$3.04M 0.03%
32,124
+49
+0.2% +$5.24K
VIV icon
302
Telefônica Brasil
VIV
$20.3B
$2.81M 0.02%
372,141
-2,557,137
-87% -$22.8M
CZR icon
303
Caesars Entertainment
CZR
$6.06B
$2.8M 0.02%
83,666
TARA icon
304
Protara Therapeutics
TARA
$223M
$2.73M 0.02%
+517,152
New +$1.67M
VINP icon
305
Vinci Compass Investments Ltd
VINP
$650M
$2.66M 0.02%
263,726
+109,568
+71% +$1.12M
GAUZ
306
Gauzy
GAUZ
$5.23M
$2.6M 0.02%
262,149
-4,416
-2% -$38.5K
SE icon
307
Sea Limited
SE
$68.1B
$2.37M 0.02%
22,362
-558,590
-96% -$58.7M
META icon
308
Meta Platforms (Facebook)
META
$1.5T
$2.21M 0.02%
3,766
-392
-9% -$230K
AMZN icon
309
Amazon
AMZN
$3.06T
$2.18M 0.02%
9,943
+277
+3% +$56.7K
MSFT icon
310
Microsoft
MSFT
$3.62T
$2.15M 0.02%
5,104
-2,814
-36% -$1.2M
XERS icon
311
Xeris Biopharma Holdings
XERS
$1.4B
$2.01M 0.02%
+594,015
New +$1.91M
SKYE icon
312
Skye Bioscience
SKYE
$20.5M
$1.84M 0.02%
650,758
ONC
313
BeOne Medicines Ltd
ONC
$32.6B
$1.81M 0.01%
9,786
-1,796
-16% -$367K
KKR icon
314
KKR & Co
KKR
$95.7B
$1.73M 0.01%
11,696
-491
-4% -$72K
XGN icon
315
Exagen
XGN
$113M
$1.72M 0.01%
+418,505
New +$1.51M
AVGO icon
316
Broadcom
AVGO
$1.87T
$1.6M 0.01%
6,901
-2,053
-23% -$380K
PAM icon
317
Pampa Energía
PAM
$4.66B
$1.59M 0.01%
18,097
-3,330
-16% -$253K
FCNCA icon
318
First Citizens BancShares
FCNCA
$25.3B
$1.4M 0.01%
661
+63
+11% +$132K
CHT icon
319
Chunghwa Telecom
CHT
$32.9B
$1.37M 0.01%
36,471
-42,100
-54% -$1.6M
XOM icon
320
ExxonMobil
XOM
$643B
$1.37M 0.01%
12,727
-2,109
-14% -$247K
JPM icon
321
JPMorgan Chase
JPM
$937B
$1.35M 0.01%
5,642
-1,712
-23% -$399K
OVID icon
322
Ovid Therapeutics
OVID
$435M
$1.31M 0.01%
1,400,191
OLMA icon
323
Olema Pharmaceuticals
OLMA
$985M
$1.28M 0.01%
+220,264
New +$2.2M
BAC icon
324
Bank of America
BAC
$438B
$1.13M 0.01%
25,614
+4,630
+22% +$204K
MRVL icon
325
Marvell Technology
MRVL
$174B
$1.1M 0.01%
9,941
+3,986
+67% +$370K

Similar funds

Driehaus Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Driehaus Capital Management held 466 positions worth $12.1B, up 4% from $11.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Driehaus Capital Management's Q4 2024 filing shows 91 new, 122 increased, 152 reduced and 85 closed positions. Its largest new stake was Yum China: 1,381,026 shares worth $66.5M. The largest sale was Axon Enterprise, an estimated $118M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Driehaus Capital Management's largest Q4 2024 buy was Yum China: 1,381,026 shares worth $66.5M.
  • Driehaus Capital Management added most to Astera Labs in Q4 2024, an estimated $124M increase.
  • Driehaus Capital Management's biggest Q4 2024 reduction was Axon Enterprise, cutting an estimated $118M.
  • Driehaus Capital Management fully exited Wingstop in Q4 2024, selling an estimated $85.3M.
  • Driehaus Capital Management's ten largest holdings make up 19% of its $12.1B portfolio in Q4 2024.
  • Driehaus Capital Management opened 91 new positions and closed 85 in Q4 2024.
  • Driehaus Capital Management's portfolio value rose 4% quarter-over-quarter to $12.1B.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.